Follow
Federica Fogacci
Federica Fogacci
Medical and Surgical Sciences Department, University of Bologna
Verified email at studio.unibo.it
Title
Cited by
Cited by
Year
Potential role of bioactive peptides in prevention and treatment of chronic diseases: A narrative review
AFG Cicero, F Fogacci, A Colletti
British journal of pharmacology 174 (11), 1378-1394, 2017
3142017
PCSK9 induces a pro-inflammatory response in macrophages
C Ricci, M Ruscica, M Camera, L Rossetti, C Macchi, A Colciago, I Zanotti, ...
Scientific reports 8 (1), 2267, 2018
2062018
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlledá…
AFG Cicero, A Sahebkar, F Fogacci, M Bove, M Giovannini, C Borghi
European journal of nutrition 59, 477-483, 2020
1732020
Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials
S Fogacci, F Fogacci, M Banach, ED Michos, AV Hernandez, GYH Lip, ...
Clinical Nutrition 39 (6), 1742-1752, 2020
1602020
Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach
AFG Cicero, F Fogacci, A Colletti
Food & function 8 (6), 2076-2088, 2017
1592017
Safety and tolerability of available urate-lowering drugs: a critical review
L Strilchuk, F Fogacci, AF Cicero
Expert Opinion on Drug Safety 18 (4), 261-271, 2019
1582019
Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials
F Fogacci, G Tocci, V Presta, A Fratter, C Borghi, AFG Cicero
Critical reviews in food science and nutrition 59 (10), 1605-1618, 2019
1402019
Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials
F Fogacci, N Ferri, PP Toth, M Ruscica, A Corsini, AFG Cicero
Drugs 79, 751-766, 2019
1302019
Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study
AFG Cicero, F Fogacci, M Giovannini, E Grandi, M Rosticci, S D’Addato, ...
Scientific reports 8 (1), 1-6, 2018
1142018
Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials
F Fogacci, M Banach, DP Mikhailidis, E Bruckert, PP Toth, GF Watts, ...
Pharmacological research 143, 1-16, 2019
1082019
High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects
AFG Cicero, M Rosticci, F Fogacci, E Grandi, S D'Addato, C Borghi, ...
European journal of internal medicine 37, 38-42, 2017
1062017
Red yeast rice for hypercholesterolemia
AFG Cicero, F Fogacci, M Banach
Methodist DeBakey cardiovascular journal 15 (3), 192, 2019
992019
Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial
AFG Cicero, F Fogacci, M Bove, M Giovannini, C Borghi
European journal of nutrition 60, 655-663, 2021
952021
A randomized placebo-controlled clinical trial to evaluate the medium-term effects of oat fibers on human health: the beta-glucan effects on lipid profile, glycemia andá…
AFG Cicero, F Fogacci, M Veronesi, E Strocchi, E Grandi, E Rizzoli, A Poli, ...
Nutrients 12 (3), 686, 2020
872020
Circulating levels of proprotein convertase subtilisin/kexin type 9 and arterial stiffness in a large population sample: data from the Brisighella Heart Study
M Ruscica, N Ferri, F Fogacci, M Rosticci, M Botta, S Marchiano, P Magni, ...
Journal of the American Heart Association 6 (5), e005764, 2017
802017
Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar
AFG Cicero, F Fogacci, A Zambon
Journal of the American College of Cardiology 77 (5), 620-628, 2021
792021
COVID-19-related quarantine effect on dietary habits in a northern Italian rural population: data from the Brisighella Heart Study
AFG Cicero, F Fogacci, M Giovannini, M Mezzadri, E Grandi, C Borghi, ...
Nutrients 13 (2), 309, 2021
792021
Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?
AFG Cicero, F Fogacci, AP Stoian, M Vrablik, K Al Rasadi, M Banach, ...
Current atherosclerosis reports 23, 1-14, 2021
762021
Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update
AFG Cicero, F Fogacci, M Kuwabara, C Borghi
Medicina 57 (1), 58, 2021
762021
Botanicals and phytochemicals active on cognitive decline: the clinical evidence
AFG Cicero, F Fogacci, M Banach
Pharmacological research 130, 204-212, 2018
722018
The system can't perform the operation now. Try again later.
Articles 1–20